SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-005134
Filing Date
2005-01-27
Accepted
2005-01-27 15:36:04
Documents
1
Period of Report
2005-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8822
  Complete submission text file 0001209191-05-005134.txt   10474
Mailing Address
Business Address 131 CLARENDON ST BOSTON MA 02116 6172664373
VIACELL INC (Issuer) CIK: 0001114529 (see all company filings)

IRS No.: 043244816
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 6179959800
Pollard-Knight Denise (Reporting) CIK: 0001297000 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51110 | Film No.: 05553736